Cargando…
Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome
OBJECTIVES: Despite a documented clinical need, no patient reported outcome (PRO) symptom measure meeting current regulatory requirements for clinically relevant end points is available for the evaluation of treatment benefit in diarrhea-predominant IBS (IBS-D). METHODS: Patients (N=113) with IBS-D...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077041/ https://www.ncbi.nlm.nih.gov/pubmed/24964994 http://dx.doi.org/10.1038/ctg.2014.7 |
_version_ | 1782323551969214464 |
---|---|
author | Marquis, P Lasch, K E Delgado-Herrera, L Kothari, S Lembo, A Lademacher, C Spears, G Nishida, A Tesler, Waldman L Piault, E Rosa, K Zeiher, B |
author_facet | Marquis, P Lasch, K E Delgado-Herrera, L Kothari, S Lembo, A Lademacher, C Spears, G Nishida, A Tesler, Waldman L Piault, E Rosa, K Zeiher, B |
author_sort | Marquis, P |
collection | PubMed |
description | OBJECTIVES: Despite a documented clinical need, no patient reported outcome (PRO) symptom measure meeting current regulatory requirements for clinically relevant end points is available for the evaluation of treatment benefit in diarrhea-predominant IBS (IBS-D). METHODS: Patients (N=113) with IBS-D participated in five study phases: (1) eight concept elicitation focus groups (N=34), from which a 17-item IBS-D Daily Symptom Diary and four-item IBS-D Symptom Event Log (Diary and Event Log) were developed; (2) one-on-one cognitive interviews (N=11) to assess the instrument's comprehensiveness, understandability, appropriateness, and readability; (3) four data triangulation focus groups (N=32) to confirm the concepts elicited; (4) two hybrid (concept elicitation and cognitive interview) focus groups (N=16); and (5) two iterative sets of one-on-one cognitive interviews (N=20) to further clarify the symptoms of IBS-D and debrief a revised seven-item Diary and four-item Event Log. RESULTS: Of thirty-six concepts initially identified, 22 were excluded because they were not saturated, not clinically relevant, not critical symptoms of IBS-D, considered upper GI symptoms, or too broad or vaguely defined. The remaining concepts were diarrhea, immediate need (urgency), bloating/pressure, frequency of bowel movements, cramps, abdominal/stomach pain, gas, completely emptied bowels/incomplete evacuation, accidents, bubbling in intestines (bowel sounds), rectal burning, stool consistency, rectal spasm, and pain while wiping. The final instrument included a daily diary with separate items for abdominal and stomach pain and an event log with four items completed after each bowel movement as follows: (1) a record of the bowel movement/event and an assessment of (2) severity of immediacy of need/bowel urgency, (3) incomplete evacuation, and (4) stool consistency (evaluated using the newly developed Astellas Stool Form Scale). Based on rounds of interviews and clinical input, items considered secondary or nonspecific to IBS-D (rectal burning, bubbling in intestines, spasms, and pain while wiping) were excluded. CONCLUSIONS: The IBS-D Symptom Diary and Event Log represent a rigorously developed PRO instrument for the measurement of the IBS-D symptom experience from the perspective of the patient. Its content validity has been supported, and future work should evaluate the instrument's psychometric properties. |
format | Online Article Text |
id | pubmed-4077041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-40770412014-07-01 Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome Marquis, P Lasch, K E Delgado-Herrera, L Kothari, S Lembo, A Lademacher, C Spears, G Nishida, A Tesler, Waldman L Piault, E Rosa, K Zeiher, B Clin Transl Gastroenterol Functional GI Disorders OBJECTIVES: Despite a documented clinical need, no patient reported outcome (PRO) symptom measure meeting current regulatory requirements for clinically relevant end points is available for the evaluation of treatment benefit in diarrhea-predominant IBS (IBS-D). METHODS: Patients (N=113) with IBS-D participated in five study phases: (1) eight concept elicitation focus groups (N=34), from which a 17-item IBS-D Daily Symptom Diary and four-item IBS-D Symptom Event Log (Diary and Event Log) were developed; (2) one-on-one cognitive interviews (N=11) to assess the instrument's comprehensiveness, understandability, appropriateness, and readability; (3) four data triangulation focus groups (N=32) to confirm the concepts elicited; (4) two hybrid (concept elicitation and cognitive interview) focus groups (N=16); and (5) two iterative sets of one-on-one cognitive interviews (N=20) to further clarify the symptoms of IBS-D and debrief a revised seven-item Diary and four-item Event Log. RESULTS: Of thirty-six concepts initially identified, 22 were excluded because they were not saturated, not clinically relevant, not critical symptoms of IBS-D, considered upper GI symptoms, or too broad or vaguely defined. The remaining concepts were diarrhea, immediate need (urgency), bloating/pressure, frequency of bowel movements, cramps, abdominal/stomach pain, gas, completely emptied bowels/incomplete evacuation, accidents, bubbling in intestines (bowel sounds), rectal burning, stool consistency, rectal spasm, and pain while wiping. The final instrument included a daily diary with separate items for abdominal and stomach pain and an event log with four items completed after each bowel movement as follows: (1) a record of the bowel movement/event and an assessment of (2) severity of immediacy of need/bowel urgency, (3) incomplete evacuation, and (4) stool consistency (evaluated using the newly developed Astellas Stool Form Scale). Based on rounds of interviews and clinical input, items considered secondary or nonspecific to IBS-D (rectal burning, bubbling in intestines, spasms, and pain while wiping) were excluded. CONCLUSIONS: The IBS-D Symptom Diary and Event Log represent a rigorously developed PRO instrument for the measurement of the IBS-D symptom experience from the perspective of the patient. Its content validity has been supported, and future work should evaluate the instrument's psychometric properties. Nature Publishing Group 2014-06 2014-06-26 /pmc/articles/PMC4077041/ /pubmed/24964994 http://dx.doi.org/10.1038/ctg.2014.7 Text en Copyright © 2014 American College of Gastroenterology http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Functional GI Disorders Marquis, P Lasch, K E Delgado-Herrera, L Kothari, S Lembo, A Lademacher, C Spears, G Nishida, A Tesler, Waldman L Piault, E Rosa, K Zeiher, B Qualitative Development of a Patient-Reported Outcome Symptom Measure in Diarrhea-Predominant Irritable Bowel Syndrome |
title | Qualitative Development of a Patient-Reported Outcome Symptom Measure in
Diarrhea-Predominant Irritable Bowel Syndrome |
title_full | Qualitative Development of a Patient-Reported Outcome Symptom Measure in
Diarrhea-Predominant Irritable Bowel Syndrome |
title_fullStr | Qualitative Development of a Patient-Reported Outcome Symptom Measure in
Diarrhea-Predominant Irritable Bowel Syndrome |
title_full_unstemmed | Qualitative Development of a Patient-Reported Outcome Symptom Measure in
Diarrhea-Predominant Irritable Bowel Syndrome |
title_short | Qualitative Development of a Patient-Reported Outcome Symptom Measure in
Diarrhea-Predominant Irritable Bowel Syndrome |
title_sort | qualitative development of a patient-reported outcome symptom measure in
diarrhea-predominant irritable bowel syndrome |
topic | Functional GI Disorders |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077041/ https://www.ncbi.nlm.nih.gov/pubmed/24964994 http://dx.doi.org/10.1038/ctg.2014.7 |
work_keys_str_mv | AT marquisp qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT laschke qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT delgadoherreral qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT kotharis qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT lemboa qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT lademacherc qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT spearsg qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT nishidaa qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT teslerwaldmanl qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT piaulte qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT rosak qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome AT zeiherb qualitativedevelopmentofapatientreportedoutcomesymptommeasureindiarrheapredominantirritablebowelsyndrome |